Unique Ingredient Identifier 6OZP39ZG8H is listed as a ingredient substance
| RN | 9005-65-6 |
| NCIT | C80656 |
| RXCUI | 8560 |
| MF | Polymer substance not supported |
UNII 6OZP39ZG8H POLYSORBATE 80 is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| AURICULAR (OTIC) | SOLUTION | 0.2 % |
| AURICULAR (OTIC) | SOLUTION, DROPS | 2.5 % |
| AURICULAR (OTIC) | SUSPENSION | 5 % |
| IM - IV | INJECTION | NA |
| INHALATION | AEROSOL | 0.02 ug |
| INHALATION | POWDER | 0.22 MG |
| INHALATION | SUSPENSION | 0.37 mg/2mL |
| INHALATION | SUSPENSION, FOR INHALATION | 0.02 % |
| INTRA-ARTERIAL | SUSPENSION, INJECTION | 1.94 mg/1mL |
| INTRA-ARTICULAR | INJECTABLE | 0.04 % |
| INTRA-ARTICULAR | INJECTION | 0.4 % |
| INTRA-ARTICULAR | INJECTION, SUSPENSION, EXTENDED RELEASE | 5 MG |
| INTRA-ARTICULAR | INJECTION, SUSTAINED ACTION | NA |
| INTRABURSAL | INJECTION | 0.04 % |
| INTRADERMAL | INJECTION | NA |
| INTRADERMAL | INJECTION, SUSTAINED ACTION | NA |
| INTRALESIONAL | INJECTABLE | 0.19 % |
| INTRALESIONAL | INJECTION | 0.2 % |
| INTRALESIONAL | INJECTION, SUSTAINED ACTION | NA |
| INTRALESIONAL | SUSPENSION, INJECTION | 1.94 mg/1mL |
| INTRALESIONAL | SUSPENSION, INJECTION | 0.19 % |
| INTRAMUSCULAR | INJECTABLE | 1 mg |
| INTRAMUSCULAR | INJECTABLE | 0.19 %W/V |
| INTRAMUSCULAR | INJECTION | 12 % |
| INTRAMUSCULAR | INJECTION | 3.8 mg |
| INTRAMUSCULAR | INJECTION | 0.4 MG/1ML |
| INTRAMUSCULAR | INJECTION, MICROSPHERES | 0.1 % |
| INTRAMUSCULAR | INJECTION, SUSPENSION | 0.24 % |
| INTRAMUSCULAR | INJECTION, SUSTAINED ACTION | NA |
| INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION | NA |
| INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 0.2 % |
| INTRAMUSCULAR | SOLUTION, INJECTION | 5 %W/V |
| INTRAMUSCULAR | SUSPENSION | 0.02 % |
| INTRAMUSCULAR | SUSPENSION, INJECTION | 2.41 MG/1ML |
| INTRAMUSCULAR | SUSPENSION, INJECTION | 0.24 %W/V |
| INTRASYNOVIAL | INJECTABLE | 0.19 % |
| INTRASYNOVIAL | INJECTION | 0.2 % |
| INTRASYNOVIAL | INJECTION, SUSTAINED ACTION | NA |
| INTRASYNOVIAL | SUSPENSION, INJECTION | 0.19 % |
| INTRA-SYNOVIAL | SUSPENSION, INJECTION | 9.7 mg |
| INTRAVENOUS | INFUSION | NA |
| INTRAVENOUS | INJECTABLE | 63 % |
| INTRAVENOUS | INJECTION | 260 mg/1mL |
| INTRAVENOUS | INJECTION | 10 % |
| INTRAVENOUS | INJECTION, SOLUTION | 26 %W/V |
| INTRAVENOUS | INJECTION, SUSPENSION | 0.5 % |
| INTRAVENOUS | LIQUID | 400 MG/5ML |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 12 % |
| INTRAVENOUS | SOLUTION, INJECTION | 52 % |
| INTRAVENOUS | SOLUTION, LIQUID | 100 ug/1mL |
| INTRAVENOUS INFUSION | INJECTION | 260 mg/1mL |
| INTRAVITREAL | SUSPENSION, INJECTION | 0.015 % |
| IV(INFUSION) | INJECTABLE | 52 % |
| IV(INFUSION) | INJECTION | 260 mg/1mL |
| IV(INFUSION) | INJECTION | 54 % |
| IV(INFUSION) | INJECTION, SOLUTION | 54 % |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION | 5.3 % |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 12.5 % |
| IV(INFUSION) | SOLUTION | 10 % |
| IV(INFUSION) | SOLUTION, CONCENTRATE | 26 %W/V |
| IV(INFUSION) | SOLUTION, INJECTION | 58.5 % |
| NASAL | SPRAY | 106 UG/1SPRAY |
| NASAL | SPRAY | 0.5 % |
| NASAL | SPRAY, METERED | 10 % |
| NASAL | SUSPENSION | NA |
| OPHTHALMIC | DROPS | 0.1 % |
| OPHTHALMIC | EMULSION | 4 % |
| OPHTHALMIC | SOLUTION | 2.5 MG/1ML |
| OPHTHALMIC | SOLUTION | 0.2 % |
| OPHTHALMIC | SOLUTION, DROPS | 1 % |
| OPHTHALMIC | SOLUTION, GEL FORMING, EXTENDED RELEASE | 0.05 % |
| OPHTHALMIC | SUSPENSION | 0.1 % |
| OPHTHALMIC | SUSPENSION, DROPS | 0.1 % |
| ORAL | CAPSULE | 418.37 MG |
| ORAL | CAPSULE, COATED PELLETS | 0.053 MG |
| ORAL | CAPSULE, DELAYED ACTION | 3.05 MG |
| ORAL | CAPSULE, DELAYED RELEASE | 3.82 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 2 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 1.56 MG |
| ORAL | CAPSULE, HARD GELATIN | NA |
| ORAL | CAPSULE, SOFT GELATIN | 80.56 MG |
| ORAL | CAPSULE, SOFT GELATIN LIQUID-FILLED | 6 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 2.6 MG |
| ORAL | CONCENTRATE | 1 MG/1ML |
| ORAL | DROPS | 2 MG/1ML |
| ORAL | GRANULE | 20 MG |
| ORAL | GRANULE, FOR ORAL SUSPENSION | 5 MG |
| ORAL | LIQUID | NA |
| ORAL | PELLET | 1.1 MG |
| ORAL | POWDER | 66 MG/1PKT |
| ORAL | POWDER, FOR ORAL SUSPENSION | 5 MG/5ML |
| ORAL | POWDER, FOR SOLUTION | NA |
| ORAL | POWDER, FOR SUSPENSION | 5 MG/5ML |
| ORAL | SOLUTION | 126 MG/1ML |
| ORAL | SOLUTION, ELIXIR | 2.5 MG/15ML |
| ORAL | SUSPENSION | 125 MG/5ML |
| ORAL | SUSPENSION | 15 mg/1mL |
| ORAL | SUSPENSION | 1.25 mg/1.25mL |
| ORAL | SUSPENSION, DROPS | 7.5 MG/2.5ML |
| ORAL | SUSPENSION, EXTENDED RELEASE | 10 MG/5ML |
| ORAL | SUSPENSION, FOR INHALATION | 0.4 MG/2 ML |
| ORAL | SUSPENSION, LIQUID | 5 MG/5ML |
| ORAL | SUSPENSION, SUSTAINED ACTION | 5 MG |
| ORAL | SUSPENSION, SYRUP, SUSTAINED ACTION | 0.06 % |
| ORAL | TABLET | 21.25 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), COATED | 0.5 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 24 MG |
| ORAL | TABLET, COATED | 2.2 MG |
| ORAL | TABLET, CONTROLLED RELEASE | 1.635 mg |
| ORAL | TABLET, DELAYED ACTION | 1.15 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 0.17 MG |
| ORAL | TABLET, DELAYED RELEASE | 0.62 MG |
| ORAL | TABLET, EXTENDED RELEASE | 8 MG |
| ORAL | TABLET, FILM COATED | 14.8 MG |
| ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 0.12 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 5.68 mg |
| ORAL | TABLET, SUSTAINED ACTION | 0.12 MG |
| ORAL | TABLET, SUSTAINED ACTION, COATED | 8 MG |
| ORAL | TABLET, SUSTAINED ACTION, FILM COATED | 0.2 MG |
| RECTAL | ENEMA | 0.35 % |
| RECTAL | LIQUID | NA |
| RECTAL | POWDER, FOR SOLUTION | NA |
| RECTAL | SOLUTION | 0.75 % |
| RECTAL | SUPPOSITORY | 72.15 MG |
| RESPIRATORY (INHALATION) | SUSPENSION, FOR INHALATION | 0.04 % |
| SOFT TISSUE | INJECTABLE | 0.04 % |
| SOFT TISSUE | INJECTION | 0.2 % |
| SOFT TISSUE | INJECTION, SUSTAINED ACTION | NA |
| SOFT TISSUE | SUSPENSION, INJECTION | 1.94 mg/1mL |
| SOFT TISSUE | SUSPENSION, INJECTION | 0.19 % |
| SUBCUTANEOUS | INJECTION | NA |
| SUBCUTANEOUS | SUSPENSION, INJECTION | 0.46 % |
| SUBLINGUAL | TABLET | 0.075 MG |
| TOPICAL | CREAM, AUGMENTED | 15 %W/W |
| TOPICAL | CREAM, EMULSION, SUSTAINED RELEASE | 5 %W/W |
| TOPICAL | DROPS | NA |
| TOPICAL | EMULSION | 2.5 %W/W |
| TOPICAL | EMULSION, AEROSOL FOAM | 0.98 %W/W |
| TOPICAL | EMULSION, CREAM | 4.5 %W/W |
| TOPICAL | GEL | 8.5 %W/W |
| TOPICAL | LOTION | 2.5 %W/W |
| TOPICAL | OINTMENT | 0.1 %W/W |
| TOPICAL | PATCH, CONTROLLED RELEASE | NA |
| TOPICAL | SOLUTION | 2.5 MG/1ML |
| VAGINAL | CREAM | 0.001 %W/W |
| VAGINAL | EMULSION, CREAM | 0.4 % |
| VAGINAL | SUPPOSITORY | 28 MG |